Mandate

Vinge advises the sellers in the sale of Larodan AB to ABITEC Corporation

Vinge advises the owners of Larodan AB in the sale of the company to ABITEC Corporation, a subsidiary in the listed corporate group Associated British Foods, plc (“ABF”).

Larodan AB develops, manufactures and sells a broad range of high purity lipids for research and analytical purposes to customers across the world. The transaction is of strategic importance for ABITEC and ABF, as it expands the group’s product portfolio and provides ABITEC with an R&D site in Europe.

The Vinge team consisted primarily of Jesper Ottergren, Victoria Johnsson Grossman and Charlotte Akej (M&A) and Daniel Melander Björner (Employment Law).

Related

Vinge advises Aspo on its acquisition of Swed Handling

Vinge advises Aspo, listed on Nasdaq Helsinki, in the transaction whereby Aspo's subsidiary Telko expands its chemicals business in Sweden by acquiring Swed Handling, a leading Swedish chemical distributor, from TeRa Invest. As part of the transaction, Aspo’s subsidiary Leipurin expands its food industry business in Sweden, via the technical food ingredient distributor Kebelco, which is a subsidiary of Swed Handling. The closing of the transaction is subject to customary regulatory approvals.
April 30, 2024

Vinge has advised Pareto Securities in connection with a rights issue in Episurf Medical

Vinge has advised Pareto Securities in connection with a partially secured rights issue of units of up to approximately SEK 120 million in Episurf Medical.
April 24, 2024

Vinge has advised Ikano Bank AB (publ) in connection with the acquisition of a consumer credit unsecured loan portfolio from Nordnet Bank AB.

Vinge has advised Ikano Bank AB (publ) in connection with the acquisition of a consumer credit unsecured loan portfolio from Nordnet Bank AB. The final purchase price will be based on the outstanding loan volume in the portfolio as of closing date. As of March 2024, the outstanding loan volume in the portfolio amounted to approximately SEK 3.8 billion. The acquisition is subject to customary regulatory approvals.
April 22, 2024